pentobarbital will minimize the level or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers may end up in decreased serum concentrations and loss of antimalarial efficacy In individuals with hepatic dest